Lipoxin A4 as a possible mediator of the beneficial actions of phosphodiesterase-5 enzyme inhibitors

समान संसाधन

• Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19
  द्वारा: Das, Undurti N
  प्रकाशित: (2020)
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
  द्वारा: Gupta, Nitesh, और अन्य
  प्रकाशित: (2020)
• COVID-19 and Phosphodiesterase Enzyme Type 5 Inhibitors
  द्वारा: Al-Kuraishy, Hayder M., और अन्य
  प्रकाशित: (2020)
• PUFAs, BDNF and lipoxin A4 inhibit chemical-induced cytotoxicity of RIN5F cells in vitro and streptozotocin-induced type 2 diabetes mellitus in vivo
  द्वारा: Bathina, Siresha, और अन्य
  प्रकाशित: (2019)
• Lipoxins as biomarkers of lupus and other inflammatory conditions
  द्वारा: Das, Undurti N
  प्रकाशित: (2011)